Formulation Development
Silo Pharma Announces Positive Results in Alzheimer’s Disease Study
Silo Pharma, Inc. recently announced its Alzheimer’s disease therapeutic SPC-14 showed positive efficacy in small animals. Data from a study conducted at Columbia University in collaboration…
Recipharm, Medspray & Resyca Enter Exclusive License Agreement to Develop Nasally Delivered Drug Products Using Proprietary Soft Mist Technology
Recipharm recently announced an exclusive license and collaboration agreement with Medspray and Resyca to develop soft mist nasal delivery devices for single and combination drug products. This collaboration….
Ensysce Biosciences Announces FDA Breakthrough Therapy Designation Granted for PF614-MPAR
Ensysce Biosciences, Inc. recently announced receipt of notice from the US FDA that it has granted Breakthrough Therapy Designation (BTD) for PF614-MPAR. A next-generation opioid, PF614-MPAR represents a major….
Micropore Appoints Insung Chroma-Tech Co as Korean Distributor
UK-based particle engineering specialist Micropore Technologies has just announced the appointment of Insung Chroma-Tech Co. as the distributor for its patented membrane technology in the…
Colorcon Launches a New Titanium Dioxide-Free, High Opacity PVA-Based Coating for Pharmaceutical Tablets
Colorcon recently announced the launch of a new Opadry titanium dioxide (TiO2)-free film coating system for pharmaceutical tablets. Annabel Bordmann, Film Coatings General Manager, said…
Biognosys Expands US Footprint With New Proteomics CRO Facility in Massachusetts
Biognosys recently announced the operational readiness of its new proteomics facility in Massachusetts. This US expansion facilitates access to select proteomics contract research organization (CRO) services for our US biopharma customers…..
Vivtex Enters Research Collaboration With Astellas Pharma
Vivtex Corporation recently announced it has entered a research collaboration with Astellas Pharma Inc., a global pharmaceutical company. The collaboration is focused on the evaluation…
Artelo Biosciences Announces Publication of New Peer-Reviewed Preclinical Research Demonstrating Effectiveness in Treating & Preventing Oxaliplatin-Induced Peripheral Neuropathy
Artelo Biosciences, Inc. recently announced new research published in the peer-reviewed Journal of Pain. The research article, titled Discovery and preclinical evaluation of a novel inhibitor…
Alcami Announces Acquisition of West-Coast Based Pacific Pharmaceutical Services
Alcami Corporation recently announced it has completed the acquisition of Pacific Pharmaceutical Services, Inc. (PPS), a preferred provider of….
Vaxxinity Announces Collaboration on Space Medicine Research With University of Central Florida
Vaxxinity, Inc. recently announced a collaboration with the University of Central Florida (UCF) to advance space medicine research. The research, funded by a grant from the…
XOMA Expands its Commercial Royalty & Milestone Portfolio With DSUVIA Acquisition
XOMA Corporation recently announced it has acquired an economic interest in DSUVIA (sufentanil sublingual tablet) from Talphera, Inc., for $8 million. DSUVIA was approved in…
Kindeva Drug Delivery Acquires Summit Biosciences, a Specialized Nasal Drug Development & Manufacturing Organization
Kindeva Drug Delivery recently announced it has acquired Summit Biosciences Inc., an intranasal drug delivery contract development and manufacturing organization, from its founding….
Vivtex & AI Proteins Enter Strategic R&D Collaboration to Develop Novel, Oral Biologic Therapies for Inflammatory Diseases
Vivtex Corporation and AI Proteins, Inc. recently announced they have entered a strategic R&D collaboration to develop novel, oral biologic therapies for inflammatory diseases. The partners…
Orphan Drug Designation Granted to PTX-252 by FDA for the Treatment of Acute Myeloid Leukaemia
Hyloris Pharmaceuticals SA recently announced the US FDA has granted Orphan Drug Designation to PTX-252 for the treatment of Acute Myeloid Leukaemia (AML). This product…
Bora Pharmaceuticals to Acquire US Pharma Manufacturer Upsher-Smith for $210 Million in Transaction to Fuel Global Expansion
Bora Pharmaceuticals Co., Ltd. recently announced its Board of Directors has approved the acquisition of Upsher-Smith Laboratories, Inc., a generics manufacturer based in Minnesota, US, from shareholders, Sawai….
Lisata Therapeutics Announces First Patient Treated in the Phase 2a Trial of LSTA1 in Patients With Glioblastoma Multiforme
Lisata Therapeutics, Inc. recently announced treatment of the first patient in a Phase 2a trial evaluating LSTA1 in patients with newly diagnosed glioblastoma multiforme (GBM).…
Vetter Becomes Member of the German Association of Research-Based Pharmaceutical Companies (vfa)
Vetter has joined the German Association of Research-Based Pharmaceutical Companies (vfa) as an associate member. With this membership, the vfa recognizes the significant role that…
SPRIM Global Funds Prota's Promising Peanut Allergy Treatment That Results in Remission, Not Just Desensitization
Prota Therapeutics recently announced financing of $21 million in equity and debt financing. The round, led by Singapore-based SPRIM Global Investments (SGI), will help the…
Coya Therapeutics Announces Pipeline Expansion of COYA 302 to Include Frontotemporal Dementia & Parkinson’s Disease in Addition to Amyotrophic Lateral Sclerosis
Coya Therapeutics, Inc. recently announced it is expanding its pipeline in neurodegenerative conditions for COYA 302 beyond ALS to include frontotemporal dementia (FTD) and Parkinson’s…
Abzena Launches AbZelect Platforms for Improving Cell Line Development Efficiency on the Pathway to IND
Abzena has launched AbZelect and AbZelectPRO cell line development (CLD) platforms for accelerating the generation of production cell lines for manufacture of antibodies and recombinant proteins. The platforms will….
